Antigens associated with endometriosis, psoriatic arthritis and psoriasis
US9527907B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Dec 28, 2009 |
| Grant date | Dec 27, 2016 |
| Priority date | — |
| Expiry date | Mar 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/626
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Specific binding members that bind the ED-A isoform of fibronectin for use in methods of diagnosis, detection, imaging and/or treatment of endometriosis, and/or for use in delivery to the neovasculature of endometriotic tissue of a molecule conjugated to the specific binding member. Specific binding members that bind tenascin-C, especially the A1, A2, A3, A4 and/or D domain tenascin-C large isoform, for use in methods of diagnosis, detection, imaging and/or treatment of endometriosis, psoriatic arthritis or psoriasis, and/or for use in delivery to the neovasculature of endometriotic, psoriatic arthritic or psoriatic tissue of a molecule conjugated to the specific binding member.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.